Virtus ETF Advisers’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-47
Closed -$22.2K 536
2026
Q1
$22.2K Buy
47
+15
+47% +$7.55K 0.01% 438
2025
Q4
$14.9K Sell
32
-241
-88% -$112K 0.01% 444
2025
Q3
$116K Sell
273
-45
-14% -$17.4K 0.06% 299
2025
Q2
$122K Hold
318
0.07% 265
2025
Q1
$110K Buy
+318
New +$102K 0.07% 289
2019
Q3
Sell
-135
Closed -$18K 446
2019
Q2
$18K Buy
+135
New +$17.1K ﹤0.01% 374
2019
Q1
Sell
-87
Closed -$11K 191
2018
Q4
$11K Buy
+87
New +$11.7K ﹤0.01% 281

Other funds holding HCA

Virtus ETF Advisers's HCA Position: Q2 2026 in Review

Virtus ETF Advisers sold out of HCA Healthcare (HCA) in Q2 2026, closing a stake of 47 shares — an estimated $22.2K sold.

Virtus ETF Advisers first reported a position in HCA in Q4 2018 and held it in 7 quarters. The position peaked at $122K in Q2 2025. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Virtus ETF Advisers reported no remaining HCA Healthcare position as of Q2 2026 after selling out during the quarter.
  • Virtus ETF Advisers sold 47 HCA Healthcare shares in Q2 2026, an estimated $22.2K.
  • Virtus ETF Advisers first reported a position in HCA Healthcare in Q4 2018 and held it in 7 quarters.
  • Virtus ETF Advisers's HCA Healthcare position peaked at $122K in Q2 2025.
  • 1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.